Literature DB >> 16728233

Evaluating the optimal activated clotting time during carotid artery stenting.

Jacqueline Saw1, Christopher Bajzer, Ivan P Casserly, Emilio Exaire, Cameron Haery, Ravish Sachar, David Lee, Alex Abou-Chebl, Jay S Yadav.   

Abstract

Carotid artery stenting is an alternative to carotid endarterectomy for patients at high risk for surgery for carotid artery stenosis. Although unfractionated heparin is routinely used, there are no published data evaluating the optimal activated clotting time during carotid stenting. In a retrospective analysis of 605 patients who underwent carotid stenting using unfractionated heparin at the Cleveland Clinic Foundation, the optimal peak procedural activated clotting time associated with the lowest combined incidence of death, stroke, or myocardial infarction was 250 to 299 seconds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728233     DOI: 10.1016/j.amjcard.2005.12.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Adjunct bivalirudin dosing protocol for neuro-endovascular procedures.

Authors:  Alexandros L Georgiadis; Qaisar Shah; M Fareed K Suri; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2008-04

2.  Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.

Authors:  Ameer E Hassan; Muhammad Zeeshan Memon; Alexandros L Georgiadis; Gabriela Vazquez; M Fareed K Suri; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 3.  Point-of-care testing for anticoagulation monitoring in neuroendovascular procedures.

Authors:  H M Hussein; A L Georgiadis; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

Review 4.  Clinical Outcomes of Second- versus First-Generation Carotid Stents: A Systematic Review and Meta-Analysis.

Authors:  Adam Mazurek; Krzysztof Malinowski; Kenneth Rosenfield; Laura Capoccia; Francesco Speziale; Gianmarco de Donato; Carlo Setacci; Christian Wissgott; Pasqualino Sirignano; Lukasz Tekieli; Andrey Karpenko; Waclaw Kuczmik; Eugenio Stabile; David Christopher Metzger; Max Amor; Adnan H Siddiqui; Antonio Micari; Piotr Pieniążek; Alberto Cremonesi; Joachim Schofer; Andrej Schmidt; Piotr Musialek
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

5.  How Safe is Eptifibatide during Urgent Carotid Artery Stenting?

Authors:  Hesham Allam; Nirav Vora; Randall C Edgell; R Charles Callison; Yasser Al Khalili; Michelle Storkan; Amer Alshekhlee
Journal:  Front Neurol       Date:  2013-02-12       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.